Forte Biosciences (FBRX)

• Market cap: $367M
• 1 day: 0.17%
• 5 days: -7.08%
• 1 month: 11.42%
• 3 months: 120.57%
• 6 months: 187.24%
• Year to date: 23.97%
• 1 year: 83.4%
• 5 years: -96.54%
• 10 years: -99.37%
• Sector: Healthcare
• Industry: Biotechnology

About: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Employees: 16